No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss-of-function mutation carriers and wild-type subjects
Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss‐of‐function mutation carriers show different rates of sensitizat...
Saved in:
Published in | Contact dermatitis Vol. 70; no. 1; pp. 27 - 34 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.01.2014
Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0105-1873 1600-0536 1600-0536 |
DOI | 10.1111/cod.12109 |
Cover
Loading…
Abstract | Summary
Background
Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens.
Objectives
To study whether FLG loss‐of‐function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands.
Materials and Methods
Four hundred and ninety‐six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens.
Results
Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss‐of‐function mutation carriers and wild‐type subjects. For type IV allergens, significantly more FLG loss‐of‐function carriers were found to be sensitized to lanolin and p‐tert‐butylphenol‐formaldehyde resin.
Conclusions
Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. |
---|---|
AbstractList | Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens.BACKGROUNDLoss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens.To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands.OBJECTIVESTo study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands.Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens.MATERIALS AND METHODSFour hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens.Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin.RESULTSOverall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin.Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization.CONCLUSIONSProbably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. Summary Background Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss-of-function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Materials and Methods Four hundred and ninety-six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Results Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss-of-function mutation carriers and wild-type subjects. For type IV allergens, significantly more FLG loss-of-function carriers were found to be sensitized to lanolin and p-tert-butylphenol-formaldehyde resin. Conclusions Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. [PUBLICATION ABSTRACT] Summary Background Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of irritants and allergens. Objectives To study whether FLG loss‐of‐function mutation carriers show different rates of sensitization to common type I and IV allergens among patients referred for occupational contact dermatitis of the hands. Materials and Methods Four hundred and ninety‐six Caucasian patients were genotyped for four FLG null mutations and patch tested with the European baseline series. In addition, 431 patients underwent prick testing with common type I allergens. Results Overall, 67 patients showed a heterozygous mutation in the FLG alleles R501X, R2447X, S3247X, and/or 2282del4. Sensitization rates for type I allergens from a European prick test series did not show significant differences between FLG loss‐of‐function mutation carriers and wild‐type subjects. For type IV allergens, significantly more FLG loss‐of‐function carriers were found to be sensitized to lanolin and p‐tert‐butylphenol‐formaldehyde resin. Conclusions Probably a variety of immunological mechanisms other than that resulting from the filaggrin system have an impact on allergic sensitization to a greater degree. Larger cohorts may be necessary to increase the statistical power of the findings presented regarding type I and IV sensitization. |
Author | Kezic, Sanja Landeck, Lilla Visser, Maaike Brans, Richard Skudlik, Christoph John, Swen Malte |
Author_xml | – sequence: 1 givenname: Lilla surname: Landeck fullname: Landeck, Lilla email: llandeck@uos.de organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany – sequence: 2 givenname: Maaike surname: Visser fullname: Visser, Maaike organization: Coronel Institute of Occupational Health, Academic Medical Centre, University of Amsterdam, 1100 DE, Amsterdam, The Netherlands – sequence: 3 givenname: Christoph surname: Skudlik fullname: Skudlik, Christoph organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany – sequence: 4 givenname: Richard surname: Brans fullname: Brans, Richard organization: Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, 49090, Osnabrück, Germany – sequence: 5 givenname: Sanja surname: Kezic fullname: Kezic, Sanja – sequence: 6 givenname: Swen Malte surname: John fullname: John, Swen Malte |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28015237$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23848345$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkktv1DAUhS1URB-w4A8gSwgJFmn9SGJniQY6jDRqFzxmaTnONfKQ2IOdqAx_hT-LOzMtUiUQd-O7-M6Rrs85RUc-eEDoOSXnNM-FCd05ZZQ0j9AJrQkpSMXrI3RCKKkKKgU_RqcprQmhdcnkE3TMuCwlL6sT9Osq4AiDjt902wPunLUQwRtI2Hkc9ZiXYHECn9zofurRBY_HgE0YhtttuwG8wNp3ePEF676H-DWjuIXxBsDjy-Uc9yGlItjCTt7s5MM07n2MjtFBTDv9jeu7YueXpnYNZkxP0WOr-wTPDu8Z-nz5_tPsQ7G8ni9mb5eFKauyKQxhhnelbVoOmhEuhQHOK0lYI2ytKyg7y1spLWFUGCs6YW1nW9KIqqkoB36GXu99NzF8nyCNanDJQN9rD2FKipYNq-tsR_8DrRtGatmwjL58gK7DFH0-RNGK1UwSQetMvThQUztApzbR5TC26i6hDLw6ADoZ3duovXHpDydJduMic2_2nIn5vyPYe4QSddsSlVuidi3J7MUD1rh9JGPUrv-XIqcE279bq9n1uztFsVe4NMKPe0UumqoFF5VaXc3VSrD56iNfKc5_A2WQ3KQ |
CODEN | CODEDG |
CitedBy_id | crossref_primary_10_1111_bjd_14793 crossref_primary_10_1111_cod_12789 crossref_primary_10_1111_1346_8138_16087 crossref_primary_10_1684_ejd_2018_3422 crossref_primary_10_1016_j_jaci_2014_11_017 crossref_primary_10_1111_cod_13268 crossref_primary_10_1016_j_jep_2023_117065 |
Cites_doi | 10.1111/bjd.12035 10.1111/j.1600-0536.2007.01232.x 10.1111/j.1398-9995.2006.01029.x 10.1111/j.1600-0536.2012.02171.x 10.1001/archderm.1976.01630340009002 10.1016/0895-4356(96)00119-9 10.1055/s-0030-1256476 10.1016/j.jaci.2009.06.046 10.1111/bjd.12083 10.1016/j.jaci.2008.02.014 10.1038/sj.jid.5700630 10.1016/j.jaci.2009.03.036 10.2332/allergolint.10-RAI-0270 10.1016/j.jaci.2010.04.038 10.1038/sj.jid.5701190 10.1111/j.1600-0536.2010.01748.x 10.1016/j.jaci.2006.07.026 10.1136/bmj.b2433 10.1046/j.1365-2133.2001.04277.x 10.1111/j.1365-2133.2010.09708.x 10.2310/6620.2008.08022 10.1038/ng.358 10.1016/j.jaci.2006.08.030 10.1001/archderm.1989.01670150056006 10.2340/00015555-0383 10.1016/j.jaci.2008.01.026 10.1016/j.jaci.2008.01.013 10.1056/NEJMra1011040 10.1016/j.jdent.2010.11.001 10.1111/j.1600-0536.1976.tb03043.x 10.1111/j.1600-0536.2010.01815.x 10.1111/j.1365-4632.2010.04754.x 10.1007/978-3-642-03827-3_24 10.1038/sj.jid.5700739 10.1016/j.jaci.2006.05.004 |
ContentType | Journal Article |
Copyright | 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2015 INIST-CNRS 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2015 INIST-CNRS – notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.1111/cod.12109 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0536 |
EndPage | 34 |
ExternalDocumentID | 3310043401 23848345 28015237 10_1111_cod_12109 COD12109 ark_67375_WNG_W72GWS3W_3 |
Genre | article Journal Article |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABHFT ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F3I F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LMP LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION IQODW AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
ID | FETCH-LOGICAL-c4549-c02c3d4f9b3ea20387ce33580297f6a5e4df3b88f0217cf7d7ffdfb09759513e3 |
IEDL.DBID | DR2 |
ISSN | 0105-1873 1600-0536 |
IngestDate | Fri Jul 11 04:14:54 EDT 2025 Fri Jul 11 07:05:51 EDT 2025 Fri Jul 25 19:09:22 EDT 2025 Mon Jul 21 06:04:53 EDT 2025 Wed Apr 02 07:25:26 EDT 2025 Tue Jul 01 03:41:39 EDT 2025 Thu Apr 24 22:58:55 EDT 2025 Wed Jan 22 17:10:54 EST 2025 Wed Oct 30 09:54:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Immunopathology Allergy Skin disease Prick test Patch test allergens filaggrin gene Contact dermatitis Gene loss-of-function mutations Sensitization Mutation Allergen contact dermatitis patch test prick test |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4549-c02c3d4f9b3ea20387ce33580297f6a5e4df3b88f0217cf7d7ffdfb09759513e3 |
Notes | istex:B8F2718F3671F1A273752FDF806833AE662CE019 ark:/67375/WNG-W72GWS3W-3 ArticleID:COD12109 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 23848345 |
PQID | 1526280716 |
PQPubID | 105341 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1492660291 proquest_miscellaneous_1469206892 proquest_journals_1526280716 pubmed_primary_23848345 pascalfrancis_primary_28015237 crossref_primary_10_1111_cod_12109 crossref_citationtrail_10_1111_cod_12109 wiley_primary_10_1111_cod_12109_COD12109 istex_primary_ark_67375_WNG_W72GWS3W_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-01 January 2014 2014-01-00 2014 2014-Jan 20140101 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: Malden |
PublicationTitle | Contact dermatitis |
PublicationTitleAlternate | Contact Dermatitis |
PublicationYear | 2014 |
Publisher | Blackwell Publishing Ltd Blackwell Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell – name: Wiley Subscription Services, Inc |
References | Fallon P G, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009: 41: 602-608. Novak N, Baurecht H, Schäfer T et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008: 128: 1430-1435. Marenholz I, Nickel R, Rüschendorf F et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006: 118: 866-871. Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown S J, Cordell H J, Irvine A D, Weidinger S. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009: 123: 1361-1370. Thyssen J P, Carlsen B C, Menné T. Nickel sensitization, hand eczema, and loss-of-function mutations in the filaggrin gene. Dermatitis 2008: 19: 303-307. Ruëff F, Bergmann K C, Brockow K et al. Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology. Pneumologie 2011: 65: 484-495. Wakelin S H, Smith H, White I R, Rycroft R J, McFadden J P. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001: 145: 28-31. van den Oord R A, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009: 339: b2433. Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989: 125: 366-368. Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011: 60: 1-9. Foussereau J, Cavelier C, Selig D. Occupational eczema from para-tertiary-butylphenol formaldehyde resins: a review of the sensitizing resins. Contact Dermatitis 1976: 2: 254-258. Henderson J, Northstone K, Lee S P et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008: 121: 872-877. Carlsen B C, Andersen K E, Menné T, Johansen J D. Patients with multiple contact allergies: a review. Contact Dermatitis 2008: 58: 1-8. Ying S, Meng Q, Corrigan C J, Lee T H. Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 2006: 118: 1386-1388. Ekelund E, Liedén A, Link J, Lee S P, D'Amato M, Palmer C N, Kockum I, Bradley M. Loss-of-function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families. Acta Derm Venereol 2008: 88: 15-19. Rogge J L, Hanifin J M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976: 112: 1391-1396. Carlsen B C, Meldgaard M, Hamann D et al. Latex allergy and filaggrin null mutations. J Dent 2011: 39: 128-132. Thyssen J P, Johansen J D, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010: 162: 1278-1285. Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007: 127: 724-726. Morar N, Cookson W O, Harper J I, Moffatt M F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007: 127: 1667-1672. Irvine A D, McLean W H, Leung D Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011: 365: 1315-1327. Heine G, Schnuch A, Uter W, Worm M, Information Network of Departments of Dermatology (IVDK), German Contact Dermatitis Research Group (DKG). Type-IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006: 61: 611-616. Ross-Hansen K, Menné T, Johansen J D et al. Nickel reactivity and filaggrin null mutations - evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis 2011: 64: 24-31. Brown S J, Relton C L, Liao H et al. Filaggrin null mutations and childhood AE: a population-based case-control study. J Allergy Clin Immunol 2008: 121: 940-946. Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006: 118: 214-219. Diepgen T L, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49: 1031-1038. Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol 2011: 50: 806-810. Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, AE, hay fever, and asthma in children. J Allergy Clin Immunol 2008: 121: 1203-1209. Visser M J, Landeck L, Campbell L E, McLean W H, Weidinger S, Calkoen F, John S M, Kezic S. Impact of loss-of-function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis. Br J Dermatol 2013: 168: 326-332. Landeck L, Visser M, Kezic S, John S M. Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis 2013: 68: 149-155. O'Regan G M, Kemperman P M, Sandilands A et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010: 126: 574-580. Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John S M. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol 2012: 167: 1302-1309. Scharschmidt T C, Man M Q, Hatano Y et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009: 124: 496-506. Carlsen B C, Johansen J D, Menné T, Meldgaard M, Szecsi P B, Stender S, Thyssen J P. Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010: 63: 89-95. 2001; 145 2009; 41 2012; 167 2007; 127 2011 2013; 68 2011; 60 2010; 126 2008; 19 2008; 58 1976; 2 2013; 168 2008; 128 2010; 162 2011; 39 2009; 339 2006; 118 2008; 121 2010; 63 1976; 112 2006; 61 1989; 125 2011; 50 2011; 64 2009; 123 2009; 124 2011; 65 2008; 88 1996; 49 2011; 365 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 Thyssen J P (e_1_2_7_36_1) 2008; 19 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 Rogge J L (e_1_2_7_27_1) 1976; 112 |
References_xml | – reference: Uehara M, Sawai T. A longitudinal study of contact sensitivity in patients with atopic dermatitis. Arch Dermatol 1989: 125: 366-368. – reference: Novak N, Baurecht H, Schäfer T et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008: 128: 1430-1435. – reference: Marenholz I, Nickel R, Rüschendorf F et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006: 118: 866-871. – reference: O'Regan G M, Kemperman P M, Sandilands A et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol 2010: 126: 574-580. – reference: Henderson J, Northstone K, Lee S P et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol 2008: 121: 872-877. – reference: Weidinger S, Rodríguez E, Stahl C, Wagenpfeil S, Klopp N, Illig T, Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007: 127: 724-726. – reference: Rogge J L, Hanifin J M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 1976: 112: 1391-1396. – reference: Landeck L, Visser M, Skudlik C, Brans R, Kezic S, John S M. Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy. Br J Dermatol 2012: 167: 1302-1309. – reference: Weidinger S, Illig T, Baurecht H et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006: 118: 214-219. – reference: Brown S J, Relton C L, Liao H et al. Filaggrin null mutations and childhood AE: a population-based case-control study. J Allergy Clin Immunol 2008: 121: 940-946. – reference: Carlsen B C, Meldgaard M, Hamann D et al. Latex allergy and filaggrin null mutations. J Dent 2011: 39: 128-132. – reference: Ying S, Meng Q, Corrigan C J, Lee T H. Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 2006: 118: 1386-1388. – reference: Ruëff F, Bergmann K C, Brockow K et al. Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology. Pneumologie 2011: 65: 484-495. – reference: Foussereau J, Cavelier C, Selig D. Occupational eczema from para-tertiary-butylphenol formaldehyde resins: a review of the sensitizing resins. Contact Dermatitis 1976: 2: 254-258. – reference: van den Oord R A, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009: 339: b2433. – reference: Carlsen B C, Johansen J D, Menné T, Meldgaard M, Szecsi P B, Stender S, Thyssen J P. Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic. Contact Dermatitis 2010: 63: 89-95. – reference: Irvine A D, McLean W H, Leung D Y. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011: 365: 1315-1327. – reference: Wakelin S H, Smith H, White I R, Rycroft R J, McFadden J P. A retrospective analysis of contact allergy to lanolin. Br J Dermatol 2001: 145: 28-31. – reference: Thyssen J P, Johansen J D, Linneberg A et al. The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population. Br J Dermatol 2010: 162: 1278-1285. – reference: Landeck L, Visser M, Kezic S, John S M. Genotype-phenotype associations in filaggrin loss-of-function mutation carriers. Contact Dermatitis 2013: 68: 149-155. – reference: Visser M J, Landeck L, Campbell L E, McLean W H, Weidinger S, Calkoen F, John S M, Kezic S. Impact of loss-of-function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis. Br J Dermatol 2013: 168: 326-332. – reference: Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol 2011: 50: 806-810. – reference: Rodríguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown S J, Cordell H J, Irvine A D, Weidinger S. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009: 123: 1361-1370. – reference: Carlsen B C, Andersen K E, Menné T, Johansen J D. Patients with multiple contact allergies: a review. Contact Dermatitis 2008: 58: 1-8. – reference: Morar N, Cookson W O, Harper J I, Moffatt M F. Filaggrin mutations in children with severe atopic dermatitis. J Invest Dermatol 2007: 127: 1667-1672. – reference: Diepgen T L, Sauerbrei W, Fartasch M. Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. J Clin Epidemiol 1996: 49: 1031-1038. – reference: Osawa R, Akiyama M, Shimizu H. Filaggrin gene defects and the risk of developing allergic disorders. Allergol Int 2011: 60: 1-9. – reference: Scharschmidt T C, Man M Q, Hatano Y et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009: 124: 496-506. – reference: Fallon P G, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 2009: 41: 602-608. – reference: Weidinger S, O'Sullivan M, Illig T et al. Filaggrin mutations, AE, hay fever, and asthma in children. J Allergy Clin Immunol 2008: 121: 1203-1209. – reference: Heine G, Schnuch A, Uter W, Worm M, Information Network of Departments of Dermatology (IVDK), German Contact Dermatitis Research Group (DKG). Type-IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006: 61: 611-616. – reference: Ross-Hansen K, Menné T, Johansen J D et al. Nickel reactivity and filaggrin null mutations - evaluation of the filaggrin bypass theory in a general population. Contact Dermatitis 2011: 64: 24-31. – reference: Ekelund E, Liedén A, Link J, Lee S P, D'Amato M, Palmer C N, Kockum I, Bradley M. Loss-of-function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families. Acta Derm Venereol 2008: 88: 15-19. – reference: Thyssen J P, Carlsen B C, Menné T. Nickel sensitization, hand eczema, and loss-of-function mutations in the filaggrin gene. Dermatitis 2008: 19: 303-307. – volume: 49 start-page: 1031 year: 1996 end-page: 1038 article-title: Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness publication-title: J Clin Epidemiol – volume: 123 start-page: 1361 year: 2009 end-page: 1370 article-title: Meta‐analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease publication-title: J Allergy Clin Immunol – volume: 126 start-page: 574 year: 2010 end-page: 580 article-title: Raman profiles of the stratum corneum define 3 filaggrin genotype‐determined atopic dermatitis endophenotypes publication-title: J Allergy Clin Immunol – volume: 128 start-page: 1430 year: 2008 end-page: 1435 article-title: Loss‐of‐function mutations in the filaggrin gene and allergic contact sensitization to nickel publication-title: J Invest Dermatol – volume: 127 start-page: 724 year: 2007 end-page: 726 article-title: Filaggrin mutations strongly predispose to early‐onset and extrinsic atopic dermatitis publication-title: J Invest Dermatol – volume: 39 start-page: 128 year: 2011 end-page: 132 article-title: Latex allergy and filaggrin null mutations publication-title: J Dent – volume: 168 start-page: 326 year: 2013 end-page: 332 article-title: Impact of loss‐of‐function mutations in the filaggrin gene and atopic dermatitis on the development of occupational irritant contact dermatitis publication-title: Br J Dermatol – volume: 63 start-page: 89 year: 2010 end-page: 95 article-title: Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic publication-title: Contact Dermatitis – volume: 124 start-page: 496 year: 2009 end-page: 506 article-title: Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens publication-title: J Allergy Clin Immunol – volume: 162 start-page: 1278 year: 2010 end-page: 1285 article-title: The association between null mutations in the filaggrin gene and contact sensitization to nickel and other chemicals in the general population publication-title: Br J Dermatol – volume: 145 start-page: 28 year: 2001 end-page: 31 article-title: A retrospective analysis of contact allergy to lanolin publication-title: Br J Dermatol – volume: 60 start-page: 1 year: 2011 end-page: 9 article-title: Filaggrin gene defects and the risk of developing allergic disorders publication-title: Allergol Int – volume: 112 start-page: 1391 year: 1976 end-page: 1396 article-title: Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation publication-title: Arch Dermatol – volume: 19 start-page: 303 year: 2008 end-page: 307 article-title: Nickel sensitization, hand eczema, and loss‐of‐function mutations in the filaggrin gene publication-title: Dermatitis – volume: 121 start-page: 1203 year: 2008 end-page: 1209 article-title: Filaggrin mutations, AE, hay fever, and asthma in children publication-title: J Allergy Clin Immunol – volume: 88 start-page: 15 year: 2008 end-page: 19 article-title: Loss‐of‐function variants of the filaggrin gene are associated with AE and associated phenotypes in Swedish families publication-title: Acta Derm Venereol – volume: 50 start-page: 806 year: 2011 end-page: 810 article-title: Contact sensitization pattern in 172 atopic subjects publication-title: Int J Dermatol – volume: 118 start-page: 866 year: 2006 end-page: 871 article-title: Filaggrin loss‐of‐function mutations predispose to phenotypes involved in the atopic march publication-title: J Allergy Clin Immunol – volume: 68 start-page: 149 year: 2013 end-page: 155 article-title: Genotype–phenotype associations in filaggrin loss‐of‐function mutation carriers publication-title: Contact Dermatitis – volume: 58 start-page: 1 year: 2008 end-page: 8 article-title: Patients with multiple contact allergies: a review publication-title: Contact Dermatitis – volume: 365 start-page: 1315 year: 2011 end-page: 1327 article-title: Filaggrin mutations associated with skin and allergic diseases publication-title: N Engl J Med – volume: 2 start-page: 254 year: 1976 end-page: 258 article-title: Occupational eczema from para‐tertiary‐butylphenol formaldehyde resins: a review of the sensitizing resins publication-title: Contact Dermatitis – volume: 61 start-page: 611 year: 2006 end-page: 616 article-title: Type‐IV sensitization profile of individuals with AE: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) publication-title: Allergy – volume: 41 start-page: 602 year: 2009 end-page: 608 article-title: A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming publication-title: Nat Genet – volume: 64 start-page: 24 year: 2011 end-page: 31 article-title: Nickel reactivity and filaggrin null mutations – evaluation of the filaggrin bypass theory in a general population publication-title: Contact Dermatitis – volume: 127 start-page: 1667 year: 2007 end-page: 1672 article-title: Filaggrin mutations in children with severe atopic dermatitis publication-title: J Invest Dermatol – volume: 121 start-page: 940 year: 2008 end-page: 946 article-title: Filaggrin null mutations and childhood AE: a population‐based case–control study publication-title: J Allergy Clin Immunol – volume: 118 start-page: 1386 year: 2006 end-page: 1388 article-title: Lack of filaggrin expression in the human bronchial mucosa publication-title: J Allergy Clin Immunol – volume: 167 start-page: 1302 year: 2012 end-page: 1309 article-title: Clinical course of occupational irritant contact dermatitis of the hands in relation to filaggrin genotype status and atopy publication-title: Br J Dermatol – start-page: 439 year: 2011 end-page: 464 – volume: 339 start-page: b2433 year: 2009 article-title: Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta‐analysis publication-title: BMJ – volume: 65 start-page: 484 year: 2011 end-page: 495 article-title: Skin tests for diagnostics of allergic immediate‐type reactions. Guideline of the German Society for Allergology and Clinical Immunology publication-title: Pneumologie – volume: 118 start-page: 214 year: 2006 end-page: 219 article-title: Loss‐of‐function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations publication-title: J Allergy Clin Immunol – volume: 121 start-page: 872 year: 2008 end-page: 877 article-title: The burden of disease associated with filaggrin mutations: a population‐based, longitudinal birth cohort study publication-title: J Allergy Clin Immunol – volume: 125 start-page: 366 year: 1989 end-page: 368 article-title: A longitudinal study of contact sensitivity in patients with atopic dermatitis publication-title: Arch Dermatol – ident: e_1_2_7_4_1 doi: 10.1111/bjd.12035 – ident: e_1_2_7_11_1 doi: 10.1111/j.1600-0536.2007.01232.x – ident: e_1_2_7_29_1 doi: 10.1111/j.1398-9995.2006.01029.x – ident: e_1_2_7_8_1 doi: 10.1111/j.1600-0536.2012.02171.x – volume: 112 start-page: 1391 year: 1976 ident: e_1_2_7_27_1 article-title: Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation publication-title: Arch Dermatol doi: 10.1001/archderm.1976.01630340009002 – ident: e_1_2_7_7_1 doi: 10.1016/0895-4356(96)00119-9 – ident: e_1_2_7_9_1 doi: 10.1055/s-0030-1256476 – ident: e_1_2_7_5_1 doi: 10.1016/j.jaci.2009.06.046 – ident: e_1_2_7_3_1 doi: 10.1111/bjd.12083 – ident: e_1_2_7_19_1 doi: 10.1016/j.jaci.2008.02.014 – ident: e_1_2_7_15_1 doi: 10.1038/sj.jid.5700630 – ident: e_1_2_7_25_1 doi: 10.1016/j.jaci.2009.03.036 – ident: e_1_2_7_23_1 doi: 10.2332/allergolint.10-RAI-0270 – ident: e_1_2_7_16_1 doi: 10.1016/j.jaci.2010.04.038 – ident: e_1_2_7_34_1 doi: 10.1038/sj.jid.5701190 – ident: e_1_2_7_31_1 doi: 10.1111/j.1600-0536.2010.01748.x – ident: e_1_2_7_13_1 doi: 10.1016/j.jaci.2006.07.026 – ident: e_1_2_7_20_1 doi: 10.1136/bmj.b2433 – ident: e_1_2_7_32_1 doi: 10.1046/j.1365-2133.2001.04277.x – ident: e_1_2_7_17_1 doi: 10.1111/j.1365-2133.2010.09708.x – volume: 19 start-page: 303 year: 2008 ident: e_1_2_7_36_1 article-title: Nickel sensitization, hand eczema, and loss‐of‐function mutations in the filaggrin gene publication-title: Dermatitis doi: 10.2310/6620.2008.08022 – ident: e_1_2_7_6_1 doi: 10.1038/ng.358 – ident: e_1_2_7_24_1 doi: 10.1016/j.jaci.2006.08.030 – ident: e_1_2_7_28_1 doi: 10.1001/archderm.1989.01670150056006 – ident: e_1_2_7_12_1 doi: 10.2340/00015555-0383 – ident: e_1_2_7_18_1 doi: 10.1016/j.jaci.2008.01.026 – ident: e_1_2_7_22_1 doi: 10.1016/j.jaci.2008.01.013 – ident: e_1_2_7_2_1 doi: 10.1056/NEJMra1011040 – ident: e_1_2_7_26_1 doi: 10.1016/j.jdent.2010.11.001 – ident: e_1_2_7_33_1 doi: 10.1111/j.1600-0536.1976.tb03043.x – ident: e_1_2_7_35_1 doi: 10.1111/j.1600-0536.2010.01815.x – ident: e_1_2_7_30_1 doi: 10.1111/j.1365-4632.2010.04754.x – ident: e_1_2_7_10_1 doi: 10.1007/978-3-642-03827-3_24 – ident: e_1_2_7_21_1 doi: 10.1038/sj.jid.5700739 – ident: e_1_2_7_14_1 doi: 10.1016/j.jaci.2006.05.004 |
SSID | ssj0016428 |
Score | 2.0911517 |
Snippet | Summary
Background
Loss‐of‐function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased... Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased penetration of... Summary Background Loss-of-function mutations in the filaggrin gene (FLG) have been associated with reduced skin barrier function, possibly allowing increased... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 27 |
SubjectTerms | Adolescent Adult Aged allergens Allergens - genetics Allergens - immunology Allergic diseases Biological and medical sciences Cohort Studies contact dermatitis Dermatitis, Allergic Contact - diagnosis Dermatitis, Allergic Contact - genetics Dermatitis, Allergic Contact - immunology Dermatitis, Occupational - diagnosis Dermatitis, Occupational - genetics Dermatitis, Occupational - immunology Female filaggrin gene Genetic Markers Genetic Predisposition to Disease Genotyping Techniques Hand Heterozygote Humans Immunopathology Intermediate Filament Proteins - deficiency Intermediate Filament Proteins - genetics Logistic Models loss-of-function mutations Male Medical sciences Middle Aged Mutation patch test prick test Skin allergic diseases. Stinging insect allergies Skin Tests Young Adult |
Title | No remarkable differences in rates of sensitization to common type I and IV allergens between FLG loss-of-function mutation carriers and wild-type subjects |
URI | https://api.istex.fr/ark:/67375/WNG-W72GWS3W-3/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcod.12109 https://www.ncbi.nlm.nih.gov/pubmed/23848345 https://www.proquest.com/docview/1526280716 https://www.proquest.com/docview/1469206892 https://www.proquest.com/docview/1492660291 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9RAEF9KC-KL1v-xtawi4ktKkk2yCT5J610r9gS1Xh-EsLvZBWkvKbcJlD75EfwKfjU_iTObP3pSRXw5AplssnOzszM7M78h5GmaSBUJaXyWYguzTMcYJFQ-9gfMcpnw0GDt8NEsPTiOX58kJ2vkxVAL0-FDjAduuDKcvsYFLqT9ZZEr0C-IfoXFeyFLETd__90IHRWiXe3SFxFpM-OsRxXCLJ7xyZW9aAPZeoG5kcICe0zX1-Iqw3PVjnUb0eQm-TRMocs_Od1tG7mrLn9Dd_zPOW6SG72BSl92EnWLrOnqNrl21Ifg75Bvs5ou9UIsT7Hoig4NVkDd0M8VReAJS2tDLSbGN32RJ21qCq9e4BX4vfSQiqqkhx8pNnLB6k9L-3wxOnkzpWfArO9fvtYGfnDfdUMs2i5pgCqxxC571o0B0yqByo1qW4mHSvYuOZ68-rB34Pd9HnwVg3vqqyBSrIxNLpkWEcbTlWYYno1yblKR6Lg0TGaZQf9JGV5yY0ojg5wnYB8yze6R9aqu9ANCjQMbEmEmwTQps0DKWCR5AKPyWIqUeeT58I8XqgdBx14cZ8XgDAHLC8dyjzwZSc875I-riJ45sRkpgPuYKseTYj6bFnMeTefv2byAF--syNX4QAQmQhIx7pHtQdCKXo3YAu6kCFcUph55PN4GBYBRHVHpurXou-VRkGZ59DeaHAwx4GfokfudEP_8AJbhgXICrHGi-OfJFntv993Fw38n3SLXwcSMu0OrbbLeLFv9CMy4Ru649foD3TZF7g |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVKK0FfuF8CpRiEEC-pkjhXiRfUshfYXSRo2b5Ulu3YUtVugjZZCfHEJ_AL_BpfwoxzgUUFIV5WkTJx4tmxfWY8PkPI0ziSKhDSuCzGEmapDnGTULlYHzDNZJT4Bs8OT2fx6Ch8fRwdb5AX3VmYhh-iD7jhyLDzNQ5wDEj_MsoVTDBIf5VdIlshAA10vQ7e9eRRPiJrm8CIXJtpwlpeIczj6R9dW422ULGfMDtSVKAg01S2uAh6riNZuxQNrpGTrhNNBsrZ3qqWe-rzb_yO_9vL6-Rqi1Hpy8aobpANXdwkl6ftLvwt8m1W0qVeiOUZnruiXY0VmHHoaUGRe6KipaEV5sbX7TlPWpcU3r3AK3B96ZiKIqfjDxRrueAB0Iq2KWN0MBnSc9DW9y9fSwM_uPTaJharJm-AKrHEQnuVbQP6lYOUbbVaSYwrVbfJ0eDV4f7IbUs9uCoED9VVXqBYHppMMi0C3FJXmuEObZAlJhaRDnPDZJoadKGUSfLEmNxIL0sigIhMsztksygLfY9QY_mGhJ9KQCd56kkZiijzoNUklCJmDnne_eVctTzoWI7jnHf-EKicW5U75Ekv-rEh_7hI6Jm1m14CtI_ZcknE57MhnyfBcP6ezTm8eHfNsPoHAkAJUcASh-x0lsbbmaTicCdGxiI_dsjj_jbMAbixIwpdrip037LAi9Ms-JtMBlgM9Ok75G5jxT8_gKUYU45ANdYW_9xZvv_2wF7c_3fRR-TK6HA64ZPx7M0Dsg2IM2xiWDtks16u9ENAdbXctYP3BxNdSg0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKK1Vc-P8JlGIQQly2SuIkTsQJtex2oV0QULYHJMt2bAm1m1SbREKceARegVfjSZhxfmBRQYjLKlImTjw7Hn-2Z74h5FESKx1KZUcswRJmqYnwkFCPsD5gmqmYBxZzhw9nyf5R9OI4Pl4jT_tcmJYfYthww5Hh_DUO8LPc_jLINfgXZL_KLpCNKAEkgYjozcAdFSCwdvGLSLWZctbRCmEYz_DoymS0gXr9hMGRsgL92LawxXnIcxXIuplofJl86PvQBqCc7DS12tGff6N3_M9OXiGXOoRKn7UmdZWsmeIa2TzszuCvk2-zki7NQi5PMOuK9hVWwN_QjwVF5omKlpZWGBlfd1metC4pvHqBV7DwpVMqi5xO31Os5ILpnxXtAsbo-GBCT0FZ3798LS384MTrmlg0bdQA1XKJZfYq1wZ0Kwcp12rVKNxVqm6Qo_Hzd7v7o67Qw0hHsD4daT_ULI9sppiRIR6oa8PwfDbMuE1kbKLcMpWmFhdQ2vKcW5tb5Wc8BoDIDLtJ1ouyMLcJtY5tSAapAmySp75SkYwzH1rlkZIJ88iT_h8XumNBx2Icp6JfDYHKhVO5Rx4Oomct9cd5Qo-d2QwSoH2MleOxmM8mYs7Dyfwtmwt48faKXQ0PhIAR4pBxj2z1hiY6P1IJuJMgX1GQeOTBcBs8AB7ryMKUTYWLtyz0kzQL_yaTARIDfQYeudUa8c8PYCnuKMegGmeKf-6s2H215y7u_LvofbL5em8sDqazl3fJRYCbUbuBtUXW62Vj7gGkq9W2G7o_AAb6SLw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=No+remarkable+differences+in+rates+of+sensitization+to+common+type+I+and+IV+allergens+between+FLG+loss-of-function+mutation+carriers+and+wild-type+subjects&rft.jtitle=Contact+dermatitis&rft.au=LANDECK%2C+Lilla&rft.au=VISSER%2C+Maaike&rft.au=SKUDLIK%2C+Christoph&rft.au=BRANS%2C+Richard&rft.date=2014&rft.pub=Blackwell&rft.issn=0105-1873&rft.volume=70&rft.issue=1&rft.spage=27&rft.epage=34&rft_id=info:doi/10.1111%2Fcod.12109&rft.externalDBID=n%2Fa&rft.externalDocID=28015237 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-1873&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-1873&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-1873&client=summon |